New $3 TB Test Works With Tongue Swab, Saves Lives

For the first time in 150 years, doctors have a better way to test for tuberculosis, the world's deadliest infectious disease that kills over a million people annually.

The MiniDock MTB test revolutionizes TB diagnosis by using a simple tongue swab instead of phlegm, which many patients struggle to produce. Children, elderly people, and those weakened by disease can now get tested easily.

The device costs just $300 and runs tests for $3 to $4 each, making it cheaper than a microscope. It heats and spins the sample, then scans for TB bacteria DNA in minutes.

A major study across seven countries in Africa and Asia tested nearly 1,400 patients and found the new method met all World Health Organization accuracy targets. Traditional microscope tests miss actual TB cases about half the time, leaving patients sick and spreading disease while visiting multiple facilities seeking answers.

"Most of the patients who are suspected to have TB could have access to TB testing," says Alfred Andama, a microbiologist at Makerere University in Uganda. Early detection means early treatment, which stops transmission and saves lives.

The portable test works in wider settings than traditional lab equipment, bringing diagnosis directly to communities that need it most. Health workers can now test patients during their first visit instead of sending them away for weeks or months.

Dr. Adithya Cattamanchi from UC Irvine, who led the research published in the New England Journal of Medicine, sees this as a turning point. "What we hope it means is that many more people will have access to high-quality TB testing," he says.

The innovation emerged from COVID-19 pandemic research, when companies like China's Pluslife improved swab-based testing dramatically. They've now adapted that technology to fight tuberculosis.

The Ripple Effect

The test's accessibility could transform global TB care. Patients who once made three, four, or five visits to different facilities before finding TB testing can now get diagnosed immediately at local health centers.

Early diagnosis prevents the disease from worsening and stops patients from unknowingly spreading TB as they search for answers. Catching TB early also reduces the chance it becomes drug-resistant, a dangerous complication requiring different treatment.

While the test may not catch very early infections with low bacterial loads, and still needs follow-up testing for drug-resistant varieties, experts agree it represents major progress. Stop TB Partnership calls it "an amazing tool" that's generating worldwide excitement.

After more than a century and a half of using the same basic testing method, millions of people finally have access to faster, easier, and more reliable TB diagnosis.